The Anticancer activity and HSA binding properties of the structurally related platinum (II) complexes

Applied Biochemistry and Biotechnology

Volumn 167, Issue 4, 2012, Pages 861-872

  Yousefi, Reza ^a   Aghevlian, Sadaf ^a   Mokhtari, Fatemeh ^a,b   Samouei, Hamidreza ^a   Rashidi, Mehdi ^a   Nabavizadeh, S Masoud ^a   Tavaf, Zohreh ^a   Pouryasin, Zahra ^a   Niazi, Ali ^a   Faghihi, Reza ^a   Papari, Mohammad Mehdi ^b  

^a SHIRAZ UNIVERSITY   (Iran)

^b SHIRAZ UNIVERSITY OF TECHNOLOGY   (Iran)

Author keywords

2 Pheynyl pyridine; Anticancer activity; Biphosphine ligand; Fluorescence study; Platinum complexes

Indexed keywords

3-(4 ,5-DIMETHYLTHIAZOL-2-YL)-2 ,5-DIPHENYL TETRAZOLIUM BROMIDE; ANTICANCER ACTIVITIES; BINDING PARAMETER; BINDING PROPERTIES; BLOOD STREAMS; CANCER CELL LINES; CANCER CHEMOTHERAPY; CARRIER PROTEINS; CHARGE CHARACTERISTICS; COORDINATION MODES; FIVE-COORDINATED; FLUORESCENCE STUDIES; HUMAN SERUM ALBUMINS; HYDROGEN BINDING; INHIBITORY EFFECT; PLATINUM COMPLEXES; PT COMPLEXES; STRUCTURE ACTIVITY RELATIONSHIPS; TEMPLATE STRUCTURES;

BINDING ENERGY; BROMINE COMPOUNDS; CELL CULTURE; CELLS; CHEMOTHERAPY; COMPLEXATION; COORDINATION REACTIONS; DENATURATION; DISEASES; HYDROGEN; HYDROPHOBICITY; METHANE; OLIGOMERIZATION; OLIGOMERS; PLATINUM; PROTEINS; PYRIDINE;

PLATINUM COMPOUNDS;

ANTINEOPLASTIC AGENT; CISPLATIN; HUMAN SERUM ALBUMIN; LIGAND; PHOSPHINE DERIVATIVE; PLATINUM COMPLEX; PYRIDINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CELL STRAIN K 562; CELL STRAIN MCF 7; CHEMICAL STRUCTURE; COMPLEX FORMATION; DRUG DNA BINDING; DRUG PROTEIN BINDING; DRUG SYNTHESIS; FLUORESCENCE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYDROPHOBICITY; MULTIDRUG RESISTANCE; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; ORGANOPLATINUM COMPOUNDS; PROTEIN BINDING; PROTEIN DENATURATION; SERUM ALBUMIN; SPECTROMETRY, FLUORESCENCE;

EID: 84863720858     PISSN: 02732289     EISSN: 15590291     Source Type: Journal    
DOI: 10.1007/s12010-012-9733-5     Document Type: Article

References (48)

1. Utuku, S., Gumus, F., Karaoglu, T., & Özkul, A. (2007). Journal of Faculty of Pharmacy of Ankara, 36, 21-30
2. Alvarez-Valdés, A., Manual Pérez, J., López-Solera, I., Lannegrand, R., Continente, J. M., Amo-Ochoa, P., et al. (2002). Journal of Medicinal Chemistry, 45, 1835-1844
3. Foltinova, V., Švihálková Šindlerová, L., Horváth, V., Sova, P., Hofmanová, J., Janisch, R., et al. (2008). Scripta Medica (BRNO), 81, 105-116
4. Bakalova, A., Varbanov, H., Buyukliev, R., Momekov, G., Ivanov, D., & Doytchinova, I. (2010). Archiv der Pharmazie (Weinheim) (Epub ahead of print).
5. Hall, M. D., Amjadi, A., Zhang, M., Beale, P. J., & Hambley, T. W. (2004). Journal of Inorganic Biochemistry, 98, 1614-1624
6. Kostova, I. (2006). Recent Patents on Anti-Cancer Drug Discovery, 1,1-22
7. Lippert, B. (Ed.). (1999). Cisplatin: chemistry and biochemistry of a leading anticancer drug. ZZürich: Wiley VCH.
8. Chijiwa, S., Masutani, C., Hanaoka, F., Iwai, S., & Kuraoka, I. (2010). Carcinogenesis, 31, 388-393
9. Manic, S., Gatti, L., Carenini, N., Fumagalli, G., Zunino, F., & Perego, P. (2003). Current Cancer Drug Targets, 3,21-29
10. Sedletska, Y., Giraud-Panis, M. J., & Malinge, J. M. (2005). Current Medicinal Chemistry. Anti-Cancer Agents, 5, 251-265.
11. Jordan, P., & Carmo-Fonseca, M. (1990). Cellular and Molecular Life Sciences, 57, 1229-1235
12. Kim, W. K., & Kwon, Y. E. (2007). Cancer Chemotheraphy and Pharmacology, 60, 237-243
13. Siddik, Z. H. (2003). Oncogene, 22, 7265-7279
14. Mandal, R., Kalke, R., & Li, X. F. (2004). Chemical Research in Toxicology, 17, 1391-1397
15. Boisdron-Celle, M., Lebouil, A., Allain, P., & Gamelin, E. (2001). Bulletin du Cancer, 8, 814-819
16. Litterst, C. L. (1984). Agents and Actions, 15, 520-524
17. Litterst, C. L., & Schweitzer, V. G. (1988). Research Communications in Chemical Pathology and Pharmacology, 61,35-48
18. Kasherman, Y., Sturup, S., & Gibson, D. (2009). Journal of Medicinal Chemistry, 52, 4319-4328
19. Stewart, D. J. (2007). Critical Reviews in Oncology/Hematology, 63,12-31
20. Galanski, M., Arion, V. B., Jakupec, M. A., & Kepler, B. K. (2003). Current Pharmaceutical Design, 9, 2078-2089
21. Kwon, Y. E., Whang, K., Park, Y., & Kim, K. H. (2003). Bioorganic & Medicinal Chemistry, 11, 1669-1676
22. Lazic, J. M., Vucicevic, L., Grguric-Sipka, S., Janjetovic, K., Kaluderovic, G. N., Misirkic, M., et al. (2010). ChemMedChem, 5, 881-889
23. Silva, H., Barra, C. V., Rocha, F. V., de Almeida, M. V., Cesar, E. T., da Silva Siqueira, L. M., et al. (2010). Chemical Biology & Drug Design, 75, 407-411
24. Farrell, N., Qu, S. Y., & Hacker, M. P. (1990). Journal of Medicinal Chemistry, 33, 2179-2184
25. Wheate, N. J., & Collins, J. G. (2005). Current Medicinal Chemistry. Anti-Cancer Agents, 5, 267-279
26. Vondálová Blanárová, O., Jelí nková, I., Szöor, A., Skender, B., Soucek, K., Horváth, V., et al. (2011). Carcinogenesis, 32,42-51
27. van der Vusse, G. J. (2009). Drug Metabolism and Pharmacokinetics, 24, 300-307
28. Lu, J., Stewart, A. J., Sadler, P. J., Pinheiro, T. J., & Blindauer, C. A. (2008). Biochemical Society Transactions, 36, 1317-1321
29. Mosmann, T. (1983). Journal of Immunological Methods, 65,55-63
30. Hawe, A., Poole, R., & Jiskoot, W. (2010). Analytical Biochemistry, 401,99-106
31. Gao, L. M., Li, R. C., & Wang, K. (1989). Journal of Inorganic Biochemistry, 36,83-92
32. Frezza, M., Dou, Q. P., Xiao, Y., Samouei, H., Rashidi, M., Samari, F., et al. (2011). Journal of Medicinal Chemistry, 54(18), 6166-6176.
33. Teixeira, L. J., Seabra, M., Reis, E., Teresa, M., Cruz, G. D., Pedroso de Lima, M. C., et al. (2004). Journal of Medicinal Chemistry, 47, 2917-2925
34. Marques, M. P. M., Gira, T. O., Maria, C., De Lima, P., Gameiro, A., Pereira, E., et al. (2002). Biochimica et Biophysica Acta, 1589,63-70
35. Benedetti, M., Malina, J., Kasparkova, J., Brabec, V., & Natile, G. (2010). Biotechnology and Molecular Biology, 5,38-45
36. Tiekink, E. R. T. (2008). InflammoPharmacology, 16, 138-142
37. Rabindra Reddy, P. (2010). Indian Journal of Chemistry, 49, 1003-1015
38. Lasic, D. D., Che, B., Stuart, M. C., Guo, L., Frederik, P. M., & Barenholz, Y. (1995). Biochimica et Biophysica Acta, 1239, 145-156
39. Gately, D. P., & Howell, S. B. (1993). British Journal of Cancer, 67, 1171-1176
40. Abu-Surrah, A. S., & Kettunen, M. (2006). Current Medicinal Chemistry, 13, 1337-1357
41. Poliseno, L., Mariani, L., Collecchi, P., Piras, A., Zaccaro, L., & Rainaldi, G. (2002). Cancer Chemotherapy and Pharmacology, 50, 127-130
42. Ding, F., Wei, L., Xi, Z., Li-Jun, W., Li, Z., & Ying, S. (2010). Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 75, 1088-1094
43. Bordbar, A. K., & Taheri-Kafrani, A. (2007). Colloids and Surfaces. B, Biointerfaces, 55,84-89
44. Chang-Ying, Y., An-Xin, H., Yi, L., Hui, T., & Song-Sheng, Q. (2005). Journal of Pharmaceutical and Biomedical Analysis, 39, 263-2677
45. Wang, T., Xiang, B., Wang, Y., Chen, C., Dong, Y., Fang, H., et al. (2008). Colloids and Surfaces. B, Biointerfaces, 65,113-119
46. Ajloo, D., Behnam, H., Saboury, A. A., Mohamadi-Zonoz, F., Ranjbar, B., Moosavi-Movahedi, A. A., et al. (2007). Bulletin of the Korean Chemical Society, 28, 730-736
47. Froehlich, E., Mandeville, J. S., Jennings, C. J., Sedaghat-Herati, R. C., & Tajmir-Riahi, H. A. (2009). The Journal of Physical Chemistry. B, 113, 6986-6993
48. Semisotnov, G. V., Rodionova, N. A., Razgulyaev, O. I., Uversky, V. N., Gripas, A. F., & Gilmanshin, R. I. (1991). Biopolymers, 31,119-128